The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...

A US biotechnology company has 3D printed a tiny functioning liver in the lab that survived just over five days -- more than twice the life expectancy of 2D versions. Presenting the results at the ...

Surgeons will perform liver resections with greater accuracy and deliver improved patient outcomes thanks to new research by Nottingham Trent University. Senior Research Fellow Richard Arm has ...

A simulated study by researchers at Western University and Lawson Health Research Institute has found a new system that uses ultrasound to construct 3D-images could make treatment of liver cancer, ...

In a bid to gain further understanding of the etiology and pathogenesis of metabolic dysfunction–associated steatohepatitis (MASH), a team of researchers has created 3D bioprinted liver models. MASH, ...

Corning Incorporated (NYSE: GLW) today announced the launch of its HepGo™ Assay-ready 3D liver spheroid kit, the first plug-and-play solution to include 96 pre-plated primary human hepatocyte (PHH) ...

With the application of a novel three-dimensional imaging technology, researchers have discovered that one portion of the autonomic nervous system in the liver undergoes severe degeneration in ...

A stained micrograph of 3D primary human liver cell tissue modeling MASH. Areas of fibrosis are indicated in blue. Image courtesy of Viscient Biosciences. Metabolic dysfunction- associated ...

CORNING, N.Y. -- Corning Incorporated (NYSE: GLW) today announced the launch of its HepGo™ Assay-ready 3D liver spheroid kit, the first plug-and-play solution to include 96 pre-plated primary human ...

Metabolic dysfunction--associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults.